Clinical event rates were still no different with longer follow-up, but one investigator thinks an advantage will emerge in ...

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time ...

Adam Langley, who works at the Essex Cardiothoracic Centre (CTC) at Basildon Hospital, has been named as one of the UK’s top ...

Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained ...

1 Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Centre for Cardiovascular Diseases, Beijing, China 2 National ...

The team from St. Luke’s Medical Center which includes Dr. Dennis Serrano, President and CEO: Dr. Sue-Ann Locnen, head of the Heart Institute; Dr. Fabio Enrique Posas, head of SLMC Center for ...

Growing demand for a minimally invasive aortic valve replacement by adults under 65 with aortic stenosis may put many at ...

Someone living with aortic stenosis that progresses quickly often has a worse outlook. But you can take steps to catch this heart issue early and work with your healthcare team to treat it. Your ...

Aortic stenosis is a narrowing of the aortic valve that produces a high-pitched “whooshing” murmur, which is often the first noticeable sign of the condition. Murmurs are graded from 1 to 6 based on ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.

The field of cardiovascular disease is increasingly focused on understanding the interconnected yet distinct nature of aortic valve disease—especially ...